BAP1介导的MAFF去泛素化调控肿瘤生长并与结直肠癌不良预后相关
该研究通过定量蛋白质组学等在结直肠癌中鉴定出MAFF为泛素-蛋白酶体轴调控的新候选底物,MAFF蛋白在癌组织较癌旁正常组织优先下调,多中心队列(训练队列546例,外部验证794例)显示MAFF蛋白低表达是总生存和无病生存的独立预测因子;机制上BAP1作为核内去泛素化酶结合并去泛素化MAFF使其稳定,进而上调DUSP5表达抑制ERK磷酸化。
要点
- MAFF蛋白在结直肠癌组织中较癌旁正常组织优先下调。
- MAFF蛋白低表达是结直肠癌总生存和无病生存的独立预测因子。
- BAP1去泛素化稳定MAFF,上调DUSP5抑制ERK磷酸化。
核心结论
- 本研究描述了一条对结直肠癌生长至关重要的新型BAP1-MAFF信号轴,可能作为治疗靶点及有前景的预后生物标志物。
研究设计与样本
- 采用定量蛋白质组学、表达模式分析及功能获得/功能缺失实验鉴定结直肠癌中受泛素-蛋白酶体轴调控的新型功能蛋白。
- 预后意义在546例患者的训练队列中评估,并在794例患者中进行外部验证。
- 通过分子生物学实验、去泛素化酶表达文库筛选和RNA测序获得机制见解。
主要发现
- MAFF蛋白是结直肠癌中受泛素-蛋白酶体调控的最主要新型候选底物。
- MAFF蛋白在结直肠癌中较癌旁正常组织优先下调。
- 多中心队列研究显示MAFF蛋白表达降低是结直肠癌患者总生存和无病生存的独立预测因子。
- 体外和体内实验显示MAFF过表达抑制结直肠癌生长,而敲低则产生相反效应。
- MAFF蛋白异常表达主要通过MAFF的泛素化调控,其中K48-泛素占主导;BAP1作为核去泛素化酶结合并去泛素化MAFF使其稳定,该稳定作用上调DUSP5表达从而抑制ERK磷酸化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite improvements in colorectal cancer (CRC) treatment, the prognosis for advanced CRC patients remains poor. Disruption of protein stability is one of the important factors in cancer development and progression. In this study, we aim to identify and analyze novel dysregulated proteins in CRC, assessing their significance and the mechanisms. METHODS: Using quantitative proteomics, expression pattern analysis, and gain-of-function/loss-of-function experiments, we identify novel functional protein dysregulated by ubiquitin-proteasome axis in CRC. Prognostic significance was evaluated in a training cohort of 546 patients and externally validated in 794 patients. Mechanistic insights are gained through molecular biology experiments, deubiquitinating enzymes (DUBs) expression library screening, and RNA sequencing. RESULTS: MAFF protein emerged as the top novel candidate substrate regulated by ubiquitin-proteasome in CRC. MAFF protein was preferentially downregulated in CRC compared to adjacent normal tissues. More importantly, multicenter cohort study identified reduced MAFF protein expression as an independent predictor of overall and disease-free survival in CRC patients. The in vitro and vivo assays showed that MAFF overexpression inhibited CRC growth, while its knockdown had the opposite effect. Intriguingly, we found the abnormal expression of MAFF protein was predominantly regulated via ubiquitination of MAFF, with K48-ubiquitin being dominant. BAP1 as a nuclear deubiquitinating enzyme (DUB), bound to and deubiquitinated MAFF, thereby stabilizing it. Such stabilization upregulated DUSP5 expression, resulting in the inhibition of ERK phosphorylation. CONCLUSIONS: This study describes a novel BAP1-MAFF signaling axis which is crucial for CRC growth, potentially serving as a therapeutic target and a promising prognostic biomarker for CRC.
引用
- Xie Z, Lin H, Huang Y, et al. BAP1-mediated MAFF deubiquitylation regulates tumor growth and is associated with adverse outcomes in colorectal cancer. Eur J Cancer. 2024. PMID: 39151323. doi:10.1016/j.ejca.2024.114278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。